| |
| | Perspectives in Psychiatric Care: Metabolic Effects Associated With Atypical Antipsychotic Medications (Site not responding. Last check: ) |
 | | Additional hypotheses point to the activity of atypical antipsychotic medication at the serotonin receptors of the beta cells in the pancreas, notably 5HT^sup 1A^ and 5HT^sub 2^ receptors; however, their roles appear complex. |
 | | Speculations about the rise in triglycerides and total cholesterol levels suggest that some atypical antipsychotic medications (e.g., olanzapine, clozapine) may increase serum LDL and triglyceride levels and lower high -density lipoprotein (HDL) cholesterol, which may be independent of weight gain (Wirshing et al, 2002). |
 | | Prior to prescribing an atypical antipsychotic medication, it is incumbent on the prescribing psychiatric nurse to perform a thorough psychiatric and medical history of the patient's current medical problems and history (e.g., diabetes, CVD), including family history, measures of weight, height, and adiposity, and to monitor these over time. |
| www.findarticles.com /p/articles/mi_qa3804/is_200404/ai_n9401763 (1287 words) |
|